http://www.dicerna.com
Dicerna Pharmaceuticals, Inc. Company Intro
Dicerna Pharmaceuticals, Inc., is a biopharmaceutical company using ribonucleic acid interference (RNAi) to develop medicines that silence genes that cause disease.
Industry
Healthcare
Dicerna Pharmaceuticals, Inc. Headquaters
33 Hayden Avenue
Lexington,02421
United States
Dicerna Pharmaceuticals, Inc. Share price
14 Sep 2022 09:05 GMT
$0
0.0 (0 %)
Dicerna Pharmaceuticals, Inc. Market cap
$
WMC RANKING
2022
Dicerna Pharmaceuticals, Inc. # 132
BiotechnologyLatest Dicerna Pharmaceuticals, Inc. News
29 Sep 2022
Liver Diseases Therapeutics Market Exhibits Higher Growth ...
According to the study, companies such as Astellas Pharma Inc., Bristol-Myers ... Inc., Protagonist Therapeutics, Inc., Dicerna Pharmaceuticals, Inc.,...
29 Sep 2022
Liver Diseases Therapeutics Market Exhibits Higher Growth ...
According to the study, companies such as Astellas Pharma Inc., Bristol-Myers ... Inc., Protagonist Therapeutics, Inc., Dicerna Pharmaceuticals, Inc.,...
26 Sep 2022
Antisense and RNAi Therapeutics Market: Production, Revenue,
Astellas Pharma Inc, Quark, Alnylam Pharmaceuticals, Inc, Dicerna Pharmaceuticals. 09-26-2022 10:58 AM CET | Health & Medicine. Press release from: Market...
WMC Market Score
WMC Market to Revenue Score
Dicerna Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Dicerna Pharmaceuticals, Inc. | USD | $177,882 | $295,031 | $-120,220 | $ | 132 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Dicerna Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
Dicerna Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Dicerna Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Dicerna Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Dicerna Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Dicerna Pharmaceuticals, Inc. | 2.84 | 11.91 | 29.51 | 0 | 0 | 0 | 18.67 |
| Regeneron Pharmaceuticals, Inc. | 0 | 0 | 0 | 22 | 0 | 0 | 9.75 |
| Vertex Pharmaceuticals Incorporated | 0 | 0 | 0 | 33 | 0 | 0 | 14.66 |
| Alexion Pharmaceuticals, Inc. | 100 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 43.17 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
